February 2016
Reactions Weekly;2/6/2016, Vol. 1587 Issue 1, p195
An abstract of the article "Primary central nervous system lymphoma in a rheumatoid arthritis patient treated with methotrexate: a case report" by H. Shimada and others is presented.


Related Articles

  • THE BIOMARKERS USED FOR DIAGNOSIS AND ASSESSMENT OF RHEUMATOID ARTHRITIS. Filipescu, Ileana Cosmina; Rednic, Simona // Romanian Journal of Rheumatology;2014, Vol. 23 Issue 1, p5 

    Significant progress in the pathogenesis, assessment and treatment of rheumatoid arthristis has been made after 1920, the year when the most frequently used remissive agents, methotrexate was introduced. The clinical and biological assessment is the "cornerstone" of monitoring any patient with...

  • Rheumatoid Nodules Developing under Methotrexate Treatment for Rheumatoid Arthritis. Duong, T. N. Y.; Blume-Peytavi, U.; Krengel, S.; Zouboulis, Ch. C.; Orfanos, C. E. // Acta Dermato-Venereologica;08/11/99, Vol. 79 Issue 5, p397 

    Focuses on the deterioration of rheumatoid nodules under methotrexate treatment for rheumatoid arthritis. Therapeutic options for methotrexate-induced rheumatoid nodules; Overview of the anti-inflammatory action of methotrexate; Indications for therapeutic interventions.

  • Three-drug combination for arthritis: The whole is greater than its parts.  // Modern Medicine;Aug96, Vol. 64 Issue 8, p56 

    Presents an abstract of a research titled `Treatment of Rheumatoid Arthritis With Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, Or a Combination of All Three Medications,' by J.R. O'Dell, C.E. Haire, N. Erikson, et al, published in the May 16, 1996 issue of `New England Journal of...

  • Inverting the pyramid: Early and aggressive treatment for rheumatoid arthritis. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;06/25/97, Vol. 10 Issue 6, p25 

    Focuses on early and aggressive treatment for rheumatoid arthritis. Conservative measures include patient education, physical modalities and nonsteroidal anti-inflammatory drugs; Use of toxic disease-modifying antirheumatic drugs during progressive state; Increasing use among rheumatologists of...

  • Double-teaming arthritis.  // U.S. News & World Report;7/31/95, Vol. 119 Issue 5, p66 

    Discusses a story published in the `New England Journal of Medicine' on treatment for rheumatoid arthritis. Finding that the drug methotrexate, taken with cyclosporine, can help relieve swelling, pain and disability for many debilitated patients; Side effects; Contact point for the American...

  • Benefits of Etanercept Use for Rheumatoid Arthritis.  // American Family Physician;5/1/2001, Vol. 63 Issue 9, p1835 

    Discusses research on the efficacy of methotrexate and etanercept in treating rheumatoid arthritis. Reference to a study led by J.M. Bathon which appeared in the November 30, 2000 issue of `New England Journal of Medicine'; Clinical and laboratory assessments conducted in the study; Benefits of...

  • Lack of association between MTHFR gene polymorphisms and response to methotrexate treatment in Pakistani patients with rheumatoid arthritis. Iqbal, Mohammad Perwaiz; Ali, Azra Arif; Mehboobali, Naseema; Iqbal, Khalida // Pakistan Journal of Pharmaceutical Sciences;Sep2015, Vol. 28 Issue 5, p1789 

    Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms have been reported to be associated with response to methotrexate (MTX) in certain populations of patients with rheumatoid arthritis (RA). This study aims at investigating any relationship of two single nucleotide polymorphisms...

  • Measuring transaminases in patients with rheumatoid arthritis on weekly methotrexate: does timing of blood testing matter? Mecoli, Christopher; Delev, Nikolay; Bingham, Clifton // Clinical Rheumatology;Dec2016, Vol. 35 Issue 12, p3053 

    The change in transaminase levels over a single week during therapy with methotrexate (MTX) has not been investigated or reported to date. In clinical practice, it is common to observe abnormal transaminase levels upon routine blood work for toxicity monitoring. Many have suggested that such lab...

  • Tc-99 m diethylenetriamine-pentaacetic acid (DTPA): is it reliable for assessment of methotrexate-induced cumulative effect on renal filtration in rheumatoid arthritis patients? Amin, Amr; Effat, Dina; Goher, Nabila; Ramadan, Basma // Rheumatology International;Dec2013, Vol. 33 Issue 12, p3059 

    Methotrexate (MTX) is commonly employed as the initial DMARD used for the treatment of rheumatoid arthritis (RA). We aimed to contribute to the safety profile of MTX by assessing its cumulative effect on renal filtration. A total of 52 RA adult female patients with normal baseline serum...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics